Profile and investment
| Fund type | Open Ended Investment Company |
|---|---|
| Investment style (stocks) | Market Cap: Large Investment Style: Growth |
| Morningstar category | Health |
| Launch date | 31 Aug 2006 |
| Price currency | USD |
| Domicile | United States |
| Symbol | HGHIX |
| Manager & start date | Rebecca Sykes 01 Sep 2020 Wen Shi 21 Jul 2021 David Khtikian 01 Mar 2022 |
| Pricing frequency | Daily |
|---|---|
| Total net assets | 1.13bn USD As of Mar 31 2024 |
| Share class size | 265.53m USD As of Mar 31 2024 |
| Net expense ratio | 1.01% |
| Front end load | -- |
| Deferred load | -- |
| Maximum Redemption Fee | -- |
| Min. initial investment | 2,000.00 USD |
| Min. additional investment | 50.00 USD |
| Initial IRA | -- |
| Additional IRA | -- |
| Available for sale | United States |
More ▼
Top 5 holdings
| Top 5 holdings as a per cent of portfolio | |||
|---|---|---|---|
| 41.04% | 30.75% | 0.00% | 30.75% |
| Category average | % Net assets | % Short | % Long |
| Company | 1 year change | Portfolio weight | Long allocation |
|---|---|---|---|
| Eli Lilly and Co LLY:NYQ | +89.84% | 10.89% | |
| UnitedHealth Group Inc UNH:NYQ | +1.53% | 6.78% | |
| Merck & Co Inc MRK:NYQ | +10.03% | 6.35% | |
| Danaher Corp DHR:NYQ | +5.35% | 3.90% | |
| Stryker Corp SYK:NYQ | +7.95% | 2.83% | |
| Per cent of portfolio in top 5 holdings: 30.75% |
Asset type
| US stock | 87.05% |
| Non-US stock | 11.81% |
| Cash | 1.14% |
| US bond | 0.00% |
| Non-US bond | 0.00% |
| Other | 0.00% |
Top 5 sectors
| Healthcare | 98.68% |
| Financial Services | 0.18% |
Top 5 regions
| United States | 87.05% |
| United Kingdom | 3.61% |
| Japan | 3.38% |
| Europe - ex Euro | 1.85% |
| Eurozone | 1.74% |
| Other | 1.22% |
Sector and region weightings are calculated using only long position holdings of the portfolio.
